MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Rare Phenomenology with Nicotinic Ganglionic Acetylcholine Receptor Antibodies

V. Melnic, J. Frey (Morgantown, USA)

Meeting: 2025 International Congress

Keywords: Acetylcholine, Myoclonus: Clinical features, Myoclonus: Etiology and Pathogenesis

Category: Autoimmune Movement Disorders

Objective: Autoimmune dysautonomia has been described in patients with positive nicotinic ganglionic (alpha-3) acetylcholine receptor antibodies (α3-AchR Ab). We present a case of myoclonus in a patient with subacute cognitive decline and elevated α3-AchR Ab level.

Background: α3-AchR mediates signal transmission across the synapses in all autonomic ganglia. Positive antibodies against α3-AchR are found in autoimmune autonomic ganglionopathy which can lead to severe diffuse autonomic failure. While there have been rare cases of movement disorders such as ataxia and parkinsonism associated with this antibody, myoclonus has not been previously reported.

Method: A 79-year-old male with no prior history of movement disorder was evaluated for progressively worsening cognitive decline and jerking that caused gait instability and falls. Examination revealed reduced short-term memory, intact cranial nerves, full strength in all four extremities, and reduced ankle reflexes. He required significant assistance to stand and ambulate. There was negative myoclonus seen with outstretched arm posture, but also truncal myoclonus and positive myoclonus of bilateral upper and lower extremities while the patient was sitting in the chair.

Results: Initial blood work revealed mild uremia and hypercapnia. MRI brain showed mild generalized parenchymal atrophy but no evidence of restricted diffusion or abnormal contrast enhancement. Continuous video EEG was negative for seizures or epileptic discharges. CSF 14-3-3 protein testing could not be performed due to the presence of blood in the CSF sample, but CSF RT-QUIC was negative. Serum paraneoplastic antibody evaluation revealed that α3-AchR Ab level was 187 (negative: < 55 pmol/L). CT chest, abdomen, and pelvis initially raised suspicion for a complex renal cyst, but PET CT was negative for malignancy. He received a five-day course of IV methylprednisolone and myoclonus significantly improved.

Conclusion: Elevated α3-AchR Ab level has been commonly associated with severe autonomic insufficiency and cases of autoimmune encephalitis have been described. While there have been rare reports of ataxia and parkinsonism associated with this antibody, we describe a case of myoclonus as a rare phenomenology seen with α3-AchR Ab mediated syndrome.

References: https://www.neurology.org/doi/10.1212/01.wnl.0000903380.14508.43

To cite this abstract in AMA style:

V. Melnic, J. Frey. Rare Phenomenology with Nicotinic Ganglionic Acetylcholine Receptor Antibodies [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/rare-phenomenology-with-nicotinic-ganglionic-acetylcholine-receptor-antibodies/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/rare-phenomenology-with-nicotinic-ganglionic-acetylcholine-receptor-antibodies/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley